63 results on '"Ishihara, Kazuyuki"'
Search Results
2. Statistical analysis of malignant melanoma : clinical features and therapeutic survival rate in terms of patients' age difference
3. Statistics for malignant melanoma in Japan: A nationwide survey conducted during the calendar years 2006 2007
4. Past statistics and prognostic factors for malignant skin tumors
5. Statistics and Prognostic Factors for Malignant Skin Tumors in Japan: Malignant Melanoma
6. Nationwide Survey of Malignant Skin Tumors (1997-2001)
7. Statistics of Malignant Melanoma(1992-1996): Epidemiology, prognostic factor and survival rates.
8. A commentary on New TNM Classification for Malignant Melanoma and Malignant Melanoma Statistics(1992-1996) Base on the Revised Staging System.
9. Evaluation Criteria for Chemotherapy for Malignant Skin Tumors.
10. A Clinical Study of 20 Patients with Angiosarcoma.
11. A Clinicopathologic Study of 45 Patients with Extramammary Paget's disease.
12. Statistical review of angiosarcoma in Japan.
13. Nationwide Survey of Malignant Melanoma (1992-1998).
14. Therapeutic Effect of OH-6000, a Natural Interferon-.GAMMA., in Patients with Adult T-Cell Leukemia. A Survey of Prognosis of Late Phase II Clinical Trial.
15. Statistics of Malignant Melanoma (1987-1991). Epidemiology, prognostic factor and 10-year survival rate.
16. Research report of gamma interferon therapy for mycosis fungoides in nationwide facilities.
17. Epidemiology of skin malignant tumor in Japan.
18. Late phase II clinical study of OH-6000 for adult T cell leukemia and lymphoma.
19. Evaluation of serum 5-S - CD value as biochemical markers of malignant melanoma ( total 66 national facilities : midterm report ).
20. Phase II clinical trial of MY-1 for adult T cell leukemia.
21. Cisplatin in progressive stage malignancy melanoma.Effect of granisetron hydrochloride on nausea and vomit caused in dacarbazine-vindesine combination therapy.
22. Skin Cancer
23. II phase test of FPI-31 ( human leucocyte interferon - .ALPHA. ) for skin malignant tumor.
24. Late phase II study of OH-6000 for mycosis fungoides.
25. Clinical phase II test of WPG for skin malignant tumors.
26. Modified fan flap for squamous cell carcinoma and two cases of the reconstruction by the arteria dorsalis pedis flap.
27. Therapeutical effect of skin malignant tumor by bleo S salve.
28. Early stage II phase clinical trial of hydrochloric acid Irinotecan (CPT-11) for skin malignant tumor.
29. Extravasation of anticancer drug and its management.
30. Clinical trial for skin malignant tumor of interferon alpha - 2a ( gene recombination ).
31. Antitumor effect of Camptothecin derivative CPT-11 for the nude mouse transplantability human squamous cell carcinoma ( SCC line ).
32. Observation of anti-tumor effects of a single and combined use of IFN-.BETA. and DAV in nude mice transplanted with human malignant lymphoma.
33. Study of anti-tumor activing of IL-1.BETA. ( OCT-43 ) nude mouse transplantabile human malignant melanoma ( SK-14 strain ) and renal cancer ( RCC-1 strain ).
34. Chemotherapy for sweat gland carcinoma.A case of sweat gland carcinoma successfully treated with chemotherapy.
35. Chemotherapy.A case of advanced stage of malignant melanoma in which CPT-11 ( Camptothecin derivative ) was effective.
36. An effective case of IFN-.BETA. for multiple skin metastases of melanoma.
37. Combined effect of DAV+rMuIFN-.BETA. for mouse B16 melanoma.
38. Combined therapy of Ferron and DAV.The study of combined therapy of Ferron and DAV for malignant melanoma.
39. Usefulness of the subsequent interferon, especially the intratumorel administration of interferon-.BETA..
40. Phase II clinical trial of human tumor necrosis factor Sertenef (PT-050) produced by recombinant DNA technology to skin malignant cancers.
41. Later phase II clinical test of MY-1 for a skin malignant tumor.
42. Antitumor effects of liblmycin (NK313) and peplomycin (PEP) on malignant melanoma transplantable to nude mouse (SK-4 strain).
43. Antitumor effects of Camptothecin driveritive CPT-11 on malignant melanom transtable to nude mouse (SK-14 strain).
44. Observation of antitumor effect of BCG live bacteria for nue mouse transplantabile human malignant melanoma.
45. A case of malignant pilomatricoma.
46. Study of antitumor activity of natural type IFN-.GAMMA.(OH-6000) for nude mouse transplantability malignant melanoma ( SK-14 line ) and renal cancer ( RCC-1 line ).
47. Antitumor effect of MY-1 for nude mouse transplantability human malignant melanoma.
48. Antitumor effect of WPG on HUMAN malignant melanoma and kidney cancers transtable to nude micl.
49. Skin Cancer
50. Skin Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.